Clinical trial
POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis (PORTEND): A Multicenter, Prospective, Observational Study
NCT02609841 is registered in ClinicalTrials.gov with ZS Pharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis (PORTEND): A Multicenter, Prospective, Observational Study
- Lead sponsor
- ZS Pharma, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- May 31, 2016
- Enrollment
- 240 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.